JBHT
63
-2
COF
67
2
ECL
52
-2
MA
51
-2
DUK
52
-2
AEP
59
-5
ITW
37
-6
WHR
50
-5
ALL
60
-3
TMO
50
-4
IFF
53
2
XRAY
28
-3
CCI
33
-5
INTU
63
7
ETN
61
-3
KMI
53
-6
LEG
58
-4
BK
68
-6
AMP
67
-5
GE
70
-2
JBHT
63
-2
COF
67
2
ECL
52
-2
MA
51
-2
DUK
52
-2
AEP
59
-5
ITW
37
-6
WHR
50
-5
ALL
60
-3
TMO
50
-4
IFF
53
2
XRAY
28
-3
CCI
33
-5
INTU
63
7
ETN
61
-3
KMI
53
-6
LEG
58
-4
BK
68
-6
AMP
67
-5
GE
70
-2
Financhill
Back

Cognizant Technology Solutions Corp. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
60

CTSH
Cognizant Technology Solutions Corp.

Last Price:
$84.25
Seasonality Move:
9.02%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.64
Seasonality Move:
11.58%
Buy
60
Cognizant Technology Solutions Corp. (CTSH) is a Buy

Is Cognizant Technology Solutions Corp. a Buy, Sell or Hold?

  • The current Cognizant Technology Solutions Corp. [CTSH] share price is $83.63. The Score for CTSH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CTSH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CTSH Stock Price Chart

What is Cognizant Technology Solutions Corp.'s stock price today?

  • The Cognizant Technology Solutions Corp. share price today is $83.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTSH is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

CTSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.09 Buy
Relative Strength Index (14 RSI): 78.31 Buy
Chaikin Money Flow: -561647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.34 - 81.76) Buy
Bollinger Bands (100): (67.31 - 76.21) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CTSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 82.63 Buy
20-day SMA: 78.71 Buy
50-day SMA: 73.46 Buy
200-day SMA: 74.58 Buy
8-day EMA: 82.51 Buy
20-day EMA: 79.5 Buy
50-day EMA: 74.09 Buy
200-day EMA: 45.59 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Cognizant Technology Solutions Corp. Earnings Growth & CTSH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.36 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Cognizant Technology Solutions Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):